Global General Anesthesia Drugs Market Growth 2022-2028
As the global economy mends, the 2021 growth of General Anesthesia Drugs will have significant change from previous year. According to our latest study, the global General Anesthesia Drugs market size is USD million in 2022 from USD 7361.3 million in 2021, with a change of % between 2021 and 2022. The global General Anesthesia Drugs market size will reach USD 8931.7 million in 2028, growing at a CAGR of 2.8% over the analysis period.
The United States General Anesthesia Drugs market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global General Anesthesia Drugs market, reaching US$ million by the year 2028. As for the Europe General Anesthesia Drugs landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main General Anesthesia Drugs players cover Astrazeneca, Fresenius-Kabi, AbbVie, and Baxter Healthcare, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of General Anesthesia Drugs market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
Propofol
Etomidate
Midazolam
Sevoflurane
Isoflurane
Others
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Intravenous Anesthetics
Inhalational Anesthetics
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Astrazeneca
Fresenius-Kabi
AbbVie
Baxter Healthcare
B.Braun
Maruishi
Piramal
Hikma Pharmaceuticals
Mylan
Nhwa
Hengrui
Lunan
Frequently Asked Questions
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
- By Type
- By Application
- By Region
- By Country
- By Manufacturer
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global General Anesthesia Drugs Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for General Anesthesia Drugs by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for General Anesthesia Drugs by Country/Region, 2017, 2022 & 2028
2.2 General Anesthesia Drugs Segment by Type
2.2.1 Propofol
2.2.2 Etomidate
2.2.3 Midazolam
2.2.4 Sevoflurane
2.2.5 Isoflurane
2.2.6 Others
2.3 General Anesthesia Drugs Sales by Type
2.3.1 Global General Anesthesia Drugs Sales Market Share by Type (2017-2022)
2.3.2 Global General Anesthesia Drugs Revenue and Market Share by Type (2017-2022)
2.3.3 Global General Anesthesia Drugs Sale Price by Type (2017-2022)
2.4 General Anesthesia Drugs Segment by Application
2.4.1 Intravenous Anesthetics
2.4.2 Inhalational Anesthetics
2.5 General Anesthesia Drugs Sales by Application
2.5.1 Global General Anesthesia Drugs Sale Market Share by Application (2017-2022)
2.5.2 Global General Anesthesia Drugs Revenue and Market Share by Application (2017-2022)
2.5.3 Global General Anesthesia Drugs Sale Price by Application (2017-2022)
3 Global General Anesthesia Drugs by Company
3.1 Global General Anesthesia Drugs Breakdown Data by Company
3.1.1 Global General Anesthesia Drugs Annual Sales by Company (2020-2022)
3.1.2 Global General Anesthesia Drugs Sales Market Share by Company (2020-2022)
3.2 Global General Anesthesia Drugs Annual Revenue by Company (2020-2022)
3.2.1 Global General Anesthesia Drugs Revenue by Company (2020-2022)
3.2.2 Global General Anesthesia Drugs Revenue Market Share by Company (2020-2022)
3.3 Global General Anesthesia Drugs Sale Price by Company
3.4 Key Manufacturers General Anesthesia Drugs Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers General Anesthesia Drugs Product Location Distribution
3.4.2 Players General Anesthesia Drugs Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for General Anesthesia Drugs by Geographic Region
4.1 World Historic General Anesthesia Drugs Market Size by Geographic Region (2017-2022)
4.1.1 Global General Anesthesia Drugs Annual Sales by Geographic Region (2017-2022)
4.1.2 Global General Anesthesia Drugs Annual Revenue by Geographic Region
4.2 World Historic General Anesthesia Drugs Market Size by Country/Region (2017-2022)
4.2.1 Global General Anesthesia Drugs Annual Sales by Country/Region (2017-2022)
4.2.2 Global General Anesthesia Drugs Annual Revenue by Country/Region
4.3 Americas General Anesthesia Drugs Sales Growth
4.4 APAC General Anesthesia Drugs Sales Growth
4.5 Europe General Anesthesia Drugs Sales Growth
4.6 Middle East & Africa General Anesthesia Drugs Sales Growth
5 Americas
5.1 Americas General Anesthesia Drugs Sales by Country
5.1.1 Americas General Anesthesia Drugs Sales by Country (2017-2022)
5.1.2 Americas General Anesthesia Drugs Revenue by Country (2017-2022)
5.2 Americas General Anesthesia Drugs Sales by Type
5.3 Americas General Anesthesia Drugs Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC General Anesthesia Drugs Sales by Region
6.1.1 APAC General Anesthesia Drugs Sales by Region (2017-2022)
6.1.2 APAC General Anesthesia Drugs Revenue by Region (2017-2022)
6.2 APAC General Anesthesia Drugs Sales by Type
6.3 APAC General Anesthesia Drugs Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe General Anesthesia Drugs by Country
7.1.1 Europe General Anesthesia Drugs Sales by Country (2017-2022)
7.1.2 Europe General Anesthesia Drugs Revenue by Country (2017-2022)
7.2 Europe General Anesthesia Drugs Sales by Type
7.3 Europe General Anesthesia Drugs Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa General Anesthesia Drugs by Country
8.1.1 Middle East & Africa General Anesthesia Drugs Sales by Country (2017-2022)
8.1.2 Middle East & Africa General Anesthesia Drugs Revenue by Country (2017-2022)
8.2 Middle East & Africa General Anesthesia Drugs Sales by Type
8.3 Middle East & Africa General Anesthesia Drugs Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of General Anesthesia Drugs
10.3 Manufacturing Process Analysis of General Anesthesia Drugs
10.4 Industry Chain Structure of General Anesthesia Drugs
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 General Anesthesia Drugs Distributors
11.3 General Anesthesia Drugs Customer
12 World Forecast Review for General Anesthesia Drugs by Geographic Region
12.1 Global General Anesthesia Drugs Market Size Forecast by Region
12.1.1 Global General Anesthesia Drugs Forecast by Region (2023-2028)
12.1.2 Global General Anesthesia Drugs Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global General Anesthesia Drugs Forecast by Type
12.7 Global General Anesthesia Drugs Forecast by Application
13 Key Players Analysis
13.1 Astrazeneca
13.1.1 Astrazeneca Company Information
13.1.2 Astrazeneca General Anesthesia Drugs Product Offered
13.1.3 Astrazeneca General Anesthesia Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Astrazeneca Main Business Overview
13.1.5 Astrazeneca Latest Developments
13.2 Fresenius-Kabi
13.2.1 Fresenius-Kabi Company Information
13.2.2 Fresenius-Kabi General Anesthesia Drugs Product Offered
13.2.3 Fresenius-Kabi General Anesthesia Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Fresenius-Kabi Main Business Overview
13.2.5 Fresenius-Kabi Latest Developments
13.3 AbbVie
13.3.1 AbbVie Company Information
13.3.2 AbbVie General Anesthesia Drugs Product Offered
13.3.3 AbbVie General Anesthesia Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 AbbVie Main Business Overview
13.3.5 AbbVie Latest Developments
13.4 Baxter Healthcare
13.4.1 Baxter Healthcare Company Information
13.4.2 Baxter Healthcare General Anesthesia Drugs Product Offered
13.4.3 Baxter Healthcare General Anesthesia Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Baxter Healthcare Main Business Overview
13.4.5 Baxter Healthcare Latest Developments
13.5 B.Braun
13.5.1 B.Braun Company Information
13.5.2 B.Braun General Anesthesia Drugs Product Offered
13.5.3 B.Braun General Anesthesia Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 B.Braun Main Business Overview
13.5.5 B.Braun Latest Developments
13.6 Maruishi
13.6.1 Maruishi Company Information
13.6.2 Maruishi General Anesthesia Drugs Product Offered
13.6.3 Maruishi General Anesthesia Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Maruishi Main Business Overview
13.6.5 Maruishi Latest Developments
13.7 Piramal
13.7.1 Piramal Company Information
13.7.2 Piramal General Anesthesia Drugs Product Offered
13.7.3 Piramal General Anesthesia Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Piramal Main Business Overview
13.7.5 Piramal Latest Developments
13.8 Hikma Pharmaceuticals
13.8.1 Hikma Pharmaceuticals Company Information
13.8.2 Hikma Pharmaceuticals General Anesthesia Drugs Product Offered
13.8.3 Hikma Pharmaceuticals General Anesthesia Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Hikma Pharmaceuticals Main Business Overview
13.8.5 Hikma Pharmaceuticals Latest Developments
13.9 Mylan
13.9.1 Mylan Company Information
13.9.2 Mylan General Anesthesia Drugs Product Offered
13.9.3 Mylan General Anesthesia Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Mylan Main Business Overview
13.9.5 Mylan Latest Developments
13.10 Nhwa
13.10.1 Nhwa Company Information
13.10.2 Nhwa General Anesthesia Drugs Product Offered
13.10.3 Nhwa General Anesthesia Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 Nhwa Main Business Overview
13.10.5 Nhwa Latest Developments
13.11 Hengrui
13.11.1 Hengrui Company Information
13.11.2 Hengrui General Anesthesia Drugs Product Offered
13.11.3 Hengrui General Anesthesia Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.11.4 Hengrui Main Business Overview
13.11.5 Hengrui Latest Developments
13.12 Lunan
13.12.1 Lunan Company Information
13.12.2 Lunan General Anesthesia Drugs Product Offered
13.12.3 Lunan General Anesthesia Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.12.4 Lunan Main Business Overview
13.12.5 Lunan Latest Developments
14 Research Findings and Conclusion
List of Tables
Table 1. General Anesthesia Drugs Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. General Anesthesia Drugs Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Propofol
Table 4. Major Players of Etomidate
Table 5. Major Players of Midazolam
Table 6. Major Players of Sevoflurane
Table 7. Major Players of Isoflurane
Table 8. Major Players of Others
Table 9. Global General Anesthesia Drugs Sales by Type (2017-2022) & (K L)
Table 10. Global General Anesthesia Drugs Sales Market Share by Type (2017-2022)
Table 11. Global General Anesthesia Drugs Revenue by Type (2017-2022) & ($ million)
Table 12. Global General Anesthesia Drugs Revenue Market Share by Type (2017-2022)
Table 13. Global General Anesthesia Drugs Sale Price by Type (2017-2022) & (US$/L)
Table 14. Global General Anesthesia Drugs Sales by Application (2017-2022) & (K L)
Table 15. Global General Anesthesia Drugs Sales Market Share by Application (2017-2022)
Table 16. Global General Anesthesia Drugs Revenue by Application (2017-2022)
Table 17. Global General Anesthesia Drugs Revenue Market Share by Application (2017-2022)
Table 18. Global General Anesthesia Drugs Sale Price by Application (2017-2022) & (US$/L)
Table 19. Global General Anesthesia Drugs Sales by Company (2020-2022) & (K L)
Table 20. Global General Anesthesia Drugs Sales Market Share by Company (2020-2022)
Table 21. Global General Anesthesia Drugs Revenue by Company (2020-2022) ($ Millions)
Table 22. Global General Anesthesia Drugs Revenue Market Share by Company (2020-2022)
Table 23. Global General Anesthesia Drugs Sale Price by Company (2020-2022) & (US$/L)
Table 24. Key Manufacturers General Anesthesia Drugs Producing Area Distribution and Sales Area
Table 25. Players General Anesthesia Drugs Products Offered
Table 26. General Anesthesia Drugs Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 27. New Products and Potential Entrants
Table 28. Mergers & Acquisitions, Expansion
Table 29. Global General Anesthesia Drugs Sales by Geographic Region (2017-2022) & (K L)
Table 30. Global General Anesthesia Drugs Sales Market Share Geographic Region (2017-2022)
Table 31. Global General Anesthesia Drugs Revenue by Geographic Region (2017-2022) & ($ millions)
Table 32. Global General Anesthesia Drugs Revenue Market Share by Geographic Region (2017-2022)
Table 33. Global General Anesthesia Drugs Sales by Country/Region (2017-2022) & (K L)
Table 34. Global General Anesthesia Drugs Sales Market Share by Country/Region (2017-2022)
Table 35. Global General Anesthesia Drugs Revenue by Country/Region (2017-2022) & ($ millions)
Table 36. Global General Anesthesia Drugs Revenue Market Share by Country/Region (2017-2022)
Table 37. Americas General Anesthesia Drugs Sales by Country (2017-2022) & (K L)
Table 38. Americas General Anesthesia Drugs Sales Market Share by Country (2017-2022)
Table 39. Americas General Anesthesia Drugs Revenue by Country (2017-2022) & ($ Millions)
Table 40. Americas General Anesthesia Drugs Revenue Market Share by Country (2017-2022)
Table 41. Americas General Anesthesia Drugs Sales by Type (2017-2022) & (K L)
Table 42. Americas General Anesthesia Drugs Sales Market Share by Type (2017-2022)
Table 43. Americas General Anesthesia Drugs Sales by Application (2017-2022) & (K L)
Table 44. Americas General Anesthesia Drugs Sales Market Share by Application (2017-2022)
Table 45. APAC General Anesthesia Drugs Sales by Region (2017-2022) & (K L)
Table 46. APAC General Anesthesia Drugs Sales Market Share by Region (2017-2022)
Table 47. APAC General Anesthesia Drugs Revenue by Region (2017-2022) & ($ Millions)
Table 48. APAC General Anesthesia Drugs Revenue Market Share by Region (2017-2022)
Table 49. APAC General Anesthesia Drugs Sales by Type (2017-2022) & (K L)
Table 50. APAC General Anesthesia Drugs Sales Market Share by Type (2017-2022)
Table 51. APAC General Anesthesia Drugs Sales by Application (2017-2022) & (K L)
Table 52. APAC General Anesthesia Drugs Sales Market Share by Application (2017-2022)
Table 53. Europe General Anesthesia Drugs Sales by Country (2017-2022) & (K L)
Table 54. Europe General Anesthesia Drugs Sales Market Share by Country (2017-2022)
Table 55. Europe General Anesthesia Drugs Revenue by Country (2017-2022) & ($ Millions)
Table 56. Europe General Anesthesia Drugs Revenue Market Share by Country (2017-2022)
Table 57. Europe General Anesthesia Drugs Sales by Type (2017-2022) & (K L)
Table 58. Europe General Anesthesia Drugs Sales Market Share by Type (2017-2022)
Table 59. Europe General Anesthesia Drugs Sales by Application (2017-2022) & (K L)
Table 60. Europe General Anesthesia Drugs Sales Market Share by Application (2017-2022)
Table 61. Middle East & Africa General Anesthesia Drugs Sales by Country (2017-2022) & (K L)
Table 62. Middle East & Africa General Anesthesia Drugs Sales Market Share by Country (2017-2022)
Table 63. Middle East & Africa General Anesthesia Drugs Revenue by Country (2017-2022) & ($ Millions)
Table 64. Middle East & Africa General Anesthesia Drugs Revenue Market Share by Country (2017-2022)
Table 65. Middle East & Africa General Anesthesia Drugs Sales by Type (2017-2022) & (K L)
Table 66. Middle East & Africa General Anesthesia Drugs Sales Market Share by Type (2017-2022)
Table 67. Middle East & Africa General Anesthesia Drugs Sales by Application (2017-2022) & (K L)
Table 68. Middle East & Africa General Anesthesia Drugs Sales Market Share by Application (2017-2022)
Table 69. Key Market Drivers & Growth Opportunities of General Anesthesia Drugs
Table 70. Key Market Challenges & Risks of General Anesthesia Drugs
Table 71. Key Industry Trends of General Anesthesia Drugs
Table 72. General Anesthesia Drugs Raw Material
Table 73. Key Suppliers of Raw Materials
Table 74. General Anesthesia Drugs Distributors List
Table 75. General Anesthesia Drugs Customer List
Table 76. Global General Anesthesia Drugs Sales Forecast by Region (2023-2028) & (K L)
Table 77. Global General Anesthesia Drugs Sales Market Forecast by Region
Table 78. Global General Anesthesia Drugs Revenue Forecast by Region (2023-2028) & ($ millions)
Table 79. Global General Anesthesia Drugs Revenue Market Share Forecast by Region (2023-2028)
Table 80. Americas General Anesthesia Drugs Sales Forecast by Country (2023-2028) & (K L)
Table 81. Americas General Anesthesia Drugs Revenue Forecast by Country (2023-2028) & ($ millions)
Table 82. APAC General Anesthesia Drugs Sales Forecast by Region (2023-2028) & (K L)
Table 83. APAC General Anesthesia Drugs Revenue Forecast by Region (2023-2028) & ($ millions)
Table 84. Europe General Anesthesia Drugs Sales Forecast by Country (2023-2028) & (K L)
Table 85. Europe General Anesthesia Drugs Revenue Forecast by Country (2023-2028) & ($ millions)
Table 86. Middle East & Africa General Anesthesia Drugs Sales Forecast by Country (2023-2028) & (K L)
Table 87. Middle East & Africa General Anesthesia Drugs Revenue Forecast by Country (2023-2028) & ($ millions)
Table 88. Global General Anesthesia Drugs Sales Forecast by Type (2023-2028) & (K L)
Table 89. Global General Anesthesia Drugs Sales Market Share Forecast by Type (2023-2028)
Table 90. Global General Anesthesia Drugs Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 91. Global General Anesthesia Drugs Revenue Market Share Forecast by Type (2023-2028)
Table 92. Global General Anesthesia Drugs Sales Forecast by Application (2023-2028) & (K L)
Table 93. Global General Anesthesia Drugs Sales Market Share Forecast by Application (2023-2028)
Table 94. Global General Anesthesia Drugs Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 95. Global General Anesthesia Drugs Revenue Market Share Forecast by Application (2023-2028)
Table 96. Astrazeneca Basic Information, General Anesthesia Drugs Manufacturing Base, Sales Area and Its Competitors
Table 97. Astrazeneca General Anesthesia Drugs Product Offered
Table 98. Astrazeneca General Anesthesia Drugs Sales (K L), Revenue ($ Million), Price (US$/L) and Gross Margin (2020-2022)
Table 99. Astrazeneca Main Business
Table 100. Astrazeneca Latest Developments
Table 101. Fresenius-Kabi Basic Information, General Anesthesia Drugs Manufacturing Base, Sales Area and Its Competitors
Table 102. Fresenius-Kabi General Anesthesia Drugs Product Offered
Table 103. Fresenius-Kabi General Anesthesia Drugs Sales (K L), Revenue ($ Million), Price (US$/L) and Gross Margin (2020-2022)
Table 104. Fresenius-Kabi Main Business
Table 105. Fresenius-Kabi Latest Developments
Table 106. AbbVie Basic Information, General Anesthesia Drugs Manufacturing Base, Sales Area and Its Competitors
Table 107. AbbVie General Anesthesia Drugs Product Offered
Table 108. AbbVie General Anesthesia Drugs Sales (K L), Revenue ($ Million), Price (US$/L) and Gross Margin (2020-2022)
Table 109. AbbVie Main Business
Table 110. AbbVie Latest Developments
Table 111. Baxter Healthcare Basic Information, General Anesthesia Drugs Manufacturing Base, Sales Area and Its Competitors
Table 112. Baxter Healthcare General Anesthesia Drugs Product Offered
Table 113. Baxter Healthcare General Anesthesia Drugs Sales (K L), Revenue ($ Million), Price (US$/L) and Gross Margin (2020-2022)
Table 114. Baxter Healthcare Main Business
Table 115. Baxter Healthcare Latest Developments
Table 116. B.Braun Basic Information, General Anesthesia Drugs Manufacturing Base, Sales Area and Its Competitors
Table 117. B.Braun General Anesthesia Drugs Product Offered
Table 118. B.Braun General Anesthesia Drugs Sales (K L), Revenue ($ Million), Price (US$/L) and Gross Margin (2020-2022)
Table 119. B.Braun Main Business
Table 120. B.Braun Latest Developments
Table 121. Maruishi Basic Information, General Anesthesia Drugs Manufacturing Base, Sales Area and Its Competitors
Table 122. Maruishi General Anesthesia Drugs Product Offered
Table 123. Maruishi General Anesthesia Drugs Sales (K L), Revenue ($ Million), Price (US$/L) and Gross Margin (2020-2022)
Table 124. Maruishi Main Business
Table 125. Maruishi Latest Developments
Table 126. Piramal Basic Information, General Anesthesia Drugs Manufacturing Base, Sales Area and Its Competitors
Table 127. Piramal General Anesthesia Drugs Product Offered
Table 128. Piramal General Anesthesia Drugs Sales (K L), Revenue ($ Million), Price (US$/L) and Gross Margin (2020-2022)
Table 129. Piramal Main Business
Table 130. Piramal Latest Developments
Table 131. Hikma Pharmaceuticals Basic Information, General Anesthesia Drugs Manufacturing Base, Sales Area and Its Competitors
Table 132. Hikma Pharmaceuticals General Anesthesia Drugs Product Offered
Table 133. Hikma Pharmaceuticals General Anesthesia Drugs Sales (K L), Revenue ($ Million), Price (US$/L) and Gross Margin (2020-2022)
Table 134. Hikma Pharmaceuticals Main Business
Table 135. Hikma Pharmaceuticals Latest Developments
Table 136. Mylan Basic Information, General Anesthesia Drugs Manufacturing Base, Sales Area and Its Competitors
Table 137. Mylan General Anesthesia Drugs Product Offered
Table 138. Mylan General Anesthesia Drugs Sales (K L), Revenue ($ Million), Price (US$/L) and Gross Margin (2020-2022)
Table 139. Mylan Main Business
Table 140. Mylan Latest Developments
Table 141. Nhwa Basic Information, General Anesthesia Drugs Manufacturing Base, Sales Area and Its Competitors
Table 142. Nhwa General Anesthesia Drugs Product Offered
Table 143. Nhwa General Anesthesia Drugs Sales (K L), Revenue ($ Million), Price (US$/L) and Gross Margin (2020-2022)
Table 144. Nhwa Main Business
Table 145. Nhwa Latest Developments
Table 146. Hengrui Basic Information, General Anesthesia Drugs Manufacturing Base, Sales Area and Its Competitors
Table 147. Hengrui General Anesthesia Drugs Product Offered
Table 148. Hengrui General Anesthesia Drugs Sales (K L), Revenue ($ Million), Price (US$/L) and Gross Margin (2020-2022)
Table 149. Hengrui Main Business
Table 150. Hengrui Latest Developments
Table 151. Lunan Basic Information, General Anesthesia Drugs Manufacturing Base, Sales Area and Its Competitors
Table 152. Lunan General Anesthesia Drugs Product Offered
Table 153. Lunan General Anesthesia Drugs Sales (K L), Revenue ($ Million), Price (US$/L) and Gross Margin (2020-2022)
Table 154. Lunan Main Business
Table 155. Lunan Latest Developments
List of Figures
Figure 1. Picture of General Anesthesia Drugs
Figure 2. General Anesthesia Drugs Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global General Anesthesia Drugs Sales Growth Rate 2017-2028 (K L)
Figure 7. Global General Anesthesia Drugs Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. General Anesthesia Drugs Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Propofol
Figure 10. Product Picture of Etomidate
Figure 11. Product Picture of Midazolam
Figure 12. Product Picture of Sevoflurane
Figure 13. Product Picture of Isoflurane
Figure 14. Product Picture of Others
Figure 15. Global General Anesthesia Drugs Sales Market Share by Type in 2021
Figure 16. Global General Anesthesia Drugs Revenue Market Share by Type (2017-2022)
Figure 17. General Anesthesia Drugs Consumed in Intravenous Anesthetics
Figure 18. Global General Anesthesia Drugs Market: Intravenous Anesthetics (2017-2022) & (K L)
Figure 19. General Anesthesia Drugs Consumed in Inhalational Anesthetics
Figure 20. Global General Anesthesia Drugs Market: Inhalational Anesthetics (2017-2022) & (K L)
Figure 21. Global General Anesthesia Drugs Sales Market Share by Application (2017-2022)
Figure 22. Global General Anesthesia Drugs Revenue Market Share by Application in 2021
Figure 23. General Anesthesia Drugs Revenue Market by Company in 2021 ($ Million)
Figure 24. Global General Anesthesia Drugs Revenue Market Share by Company in 2021
Figure 25. Global General Anesthesia Drugs Sales Market Share by Geographic Region (2017-2022)
Figure 26. Global General Anesthesia Drugs Revenue Market Share by Geographic Region in 2021
Figure 27. Global General Anesthesia Drugs Sales Market Share by Region (2017-2022)
Figure 28. Global General Anesthesia Drugs Revenue Market Share by Country/Region in 2021
Figure 29. Americas General Anesthesia Drugs Sales 2017-2022 (K L)
Figure 30. Americas General Anesthesia Drugs Revenue 2017-2022 ($ Millions)
Figure 31. APAC General Anesthesia Drugs Sales 2017-2022 (K L)
Figure 32. APAC General Anesthesia Drugs Revenue 2017-2022 ($ Millions)
Figure 33. Europe General Anesthesia Drugs Sales 2017-2022 (K L)
Figure 34. Europe General Anesthesia Drugs Revenue 2017-2022 ($ Millions)
Figure 35. Middle East & Africa General Anesthesia Drugs Sales 2017-2022 (K L)
Figure 36. Middle East & Africa General Anesthesia Drugs Revenue 2017-2022 ($ Millions)
Figure 37. Americas General Anesthesia Drugs Sales Market Share by Country in 2021
Figure 38. Americas General Anesthesia Drugs Revenue Market Share by Country in 2021
Figure 39. United States General Anesthesia Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 40. Canada General Anesthesia Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 41. Mexico General Anesthesia Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 42. Brazil General Anesthesia Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 43. APAC General Anesthesia Drugs Sales Market Share by Region in 2021
Figure 44. APAC General Anesthesia Drugs Revenue Market Share by Regions in 2021
Figure 45. China General Anesthesia Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 46. Japan General Anesthesia Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 47. South Korea General Anesthesia Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 48. Southeast Asia General Anesthesia Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 49. India General Anesthesia Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 50. Australia General Anesthesia Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 51. Europe General Anesthesia Drugs Sales Market Share by Country in 2021
Figure 52. Europe General Anesthesia Drugs Revenue Market Share by Country in 2021
Figure 53. Germany General Anesthesia Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 54. France General Anesthesia Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 55. UK General Anesthesia Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 56. Italy General Anesthesia Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 57. Russia General Anesthesia Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 58. Middle East & Africa General Anesthesia Drugs Sales Market Share by Country in 2021
Figure 59. Middle East & Africa General Anesthesia Drugs Revenue Market Share by Country in 2021
Figure 60. Egypt General Anesthesia Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 61. South Africa General Anesthesia Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 62. Israel General Anesthesia Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 63. Turkey General Anesthesia Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 64. GCC Country General Anesthesia Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 65. Manufacturing Cost Structure Analysis of General Anesthesia Drugs in 2021
Figure 66. Manufacturing Process Analysis of General Anesthesia Drugs
Figure 67. Industry Chain Structure of General Anesthesia Drugs
Figure 68. Channels of Distribution
Figure 69. Distributors Profiles
